Muscle Growth Peptide Kits
GH secretagogue research — factory-direct, batch-traceable
Key Statistics
The GH secretagogue category covers peptides that stimulate growth hormone release through distinct pituitary pathways. CJC-1295 (with DAC) provides sustained GHRH receptor activation — ideal for chronic GH elevation protocols. Ipamorelin offers the most selective ghrelin receptor agonism in the category, minimizing off-target appetite signaling compared to GHRP-2 and GHRP-6. The CJC-1295/Ipamorelin combination is our most frequently ordered pair in this category.
Product Specifications
| Product | CAS | MW (Da) | Research Context | Std. Configuration |
|---|---|---|---|---|
| CJC-1295 (DAC) | 863288-34-0 | 3,649.2 | Long-acting GHRH analogue — sustained GH pulse | 2 mg × 10 vials |
| Ipamorelin | 170851-70-4 | 711.9 | Selective GHS-R agonist — minimal hunger signal | 2 mg × 10 vials |
| GHRP-2 | 158861-67-7 | 817.0 | Potent ghrelin receptor agonist | 5 mg × 10 vials |
| GHRP-6 | 87616-84-0 | 873.0 | Ghrelin mimetic — strong GH release | 5 mg × 10 vials |
| PEG-MGF | — | 11,500 | IGF-1 splice variant — muscle stem cell activation | 1 mg × 10 vials |
| CJC-1295 (no DAC) | 863288-34-0 | 3,367.1 | Short-acting GHRH — pulse-compatible | 2 mg × 10 vials |
Protocol Combinations
CJC-1295 + Ipamorelin
DAC-GHRH + selective GHS-R
Sustained GH elevation, low side-effect
GH secretagogue research
CJC-1295 (no DAC) + GHRP-2
Pulsed GHRH + strong GHS-R
Sharp GH pulse, post-exercise window
Pulsatile GH models
CJC-1295 + Ipamorelin + PEG-MGF
GH elevation + satellite cell
GH axis coverage + repair
Regeneration protocols
FAQ
What is the difference between CJC-1295 with DAC and without DAC?
CJC-1295 with DAC (Drug Affinity Complex) binds covalently to serum albumin, extending half-life from minutes to ~8 days. This provides sustained GHRH receptor activation. The no-DAC variant produces a shorter, more physiological GH pulse — preferred when pulsatile GH release is the research objective.
Why pair CJC-1295 with Ipamorelin?
CJC-1295 amplifies the endogenous GHRH signal (the "on" switch). Ipamorelin suppresses somatostatin tone (the "off" switch) through selective ghrelin receptor agonism. Together they produce a larger net GH pulse than either peptide alone. This synergism is well-characterized in endocrinology literature.
What distinguishes Ipamorelin from GHRP-2 and GHRP-6?
Selectivity. Ipamorelin is the most selective ghrelin receptor agonist of the three, producing minimal hunger signaling and cortisol elevation at research doses. GHRP-2 and GHRP-6 are more potent GH releasers but with broader receptor profiles.
Ready to Source GH Peptides?
Bulk pricing on all six GH secretagogue peptides. COA with every order.